Psykey, Inc. (CEOS)
OTCMKTS
· Delayed Price · Currency is USD
0.0075
-0.0015 (-16.67%)
Jul 9, 2025, 4:00 PM EDT
Psykey Company Description
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.
The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.
Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes.
The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021.
Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.
Psykey, Inc.
Country | United States |
Founded | 2002 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 6 |
CEO | Michael Maher |
Contact Details
Address: 17 Belfield Road Toronto, Nevada M9W1E8 Canada | |
Phone | 888 376 8258 |
Website | psykeyworld.com |
Stock Details
Ticker Symbol | CEOS |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US1500431077 |
SIC Code | 3669 |
Key Executives
Name | Position |
---|---|
Michael Maher | Interim Chief Executive Officer |
Amar Singh Bhatal | Co-Founder, President, Secretary and Director |
Sukhinderpaul Kalsi | Co-Founder, Chief Financial Officer, Treasurer and Director |
Jacqueline Rae Danforth | Compliance Officer and Accountant |
Mark Perkell | Vice President and General Counsel |
John Gustin | Head of Global Business Development |